Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Yeong-Lim Choi"'
Autor:
Jae-Gook Shin, Young C Yoon, Im-Sook Song, Tae H Kim, Yeong H Kim, Euiyong Kim, Yeong-Lim Choi, Seok Ju Park, Hyun Joo, Sun W Kang, Ji H Son
Publikováno v:
Clinical Nephrology. 78:412-418
Azole antifungal agents are essential drugs in the treatment of fungal infections in renal transplant patients. As azoles, these antifungal agents are inhibitors of CYP3A4 and P-glycoprotein (P-gp); and thus therapeutic drug monitoring is important.
Autor:
Jinhyun Ryu, Jiyun Yoo, Seung-Ho Park, Hee Jun Cho, Kyoung Eun Baek, Min-Ju Im, Jae Won Kim, In-Koo Nam, Sang Soo Kang, In-Kyu Kim, Yeong-Lim Choi, Chang-Won Lee, Sun-Mi Park, Jungil Choi
Publikováno v:
Cancer Letters. 311:48-56
Rho GDP dissociation inhibitor (RhoGDI)2 has been identified as a regulator of Rho family GTPase. Recently, we suggested that RhoGDI2 could promote tumor growth and malignant progression in gastric cancer. In this study, we demonstrate that RhoGDI2 c
Publikováno v:
Biopharmaceutics & Drug Disposition. 32:175-184
Ketoconazole and rifampin are the most widely used compounds examined in recent drug-drug interaction (DDI) studies, and they have multiple roles in modulating drug metabolizing enzymes and transporters. To determine the underlying mechanisms of DDI,
Autor:
Wei Pan, Sang-Seop Lee, Su-Jeong Lim, Yeong-Lim Choi, Woo-Young Kim, Min-Hye Kim, Jae-Gook Shin, Im-Sook Song, Ho-Jung Shin
Publikováno v:
Xenobiotica. 41:501-510
Genetic variants of Na(+)-taurocholate co-transporting polypeptide (NTCP; SLC10A1) and ileal apical sodium-dependent bile acid transporter (ASBT; SLC10A2), which greatly contribute to bile acid homeostasis, were extensively explored in the Korean pop
Autor:
Chang-Won Lee, Seung-Ho Park, In-Koo Nam, Sun-Mi Park, Hee Jun Cho, Min-Ju Im, In-Kyu Kim, Yeong-Lim Choi, Jiyun Yoo, Oh-Hyung Kwon, Jong-Min Yoo, Soon-Chan Hong, Jae Won Kim, Young Taek Oh, Kyoung Eun Baek, Ki-Jun Ryu
Publikováno v:
Journal of proteome research. 11(4)
Rho GDP dissociation inhibitor 2 (RhoGDI2) was initially identified as a regulator of the Rho family of GTPases. Our recent works suggest that RhoGDI2 promotes tumor growth and malignant progression, as well as enhances chemoresistance in gastric can
Autor:
Gootaeg Oh, Won Sup Lee, Sang Soo Kang, Jae Yoon Han, In-Kyu Kim, Jae Won Kim, Jiyun Yoo, Dong Chul Kim, Hee Jun Cho, Jae Yong Park, Chang-Won Lee, Kyoung Eun Baek, Yeong Lim Choi, Hye Jung Cho, Sun-Mi Park, Eun Mi Hwang, Mi Ni Lee, In Koo Nam
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 15(8)
Purpose: Rho GDP dissociation inhibitor 2 (RhoGDI2) has been identified as a regulator of Rho family GTPase. However, there is currently no direct evidence suggesting whether RhoGDI2 activates or inhibits Rho family GTPase in vivo (and which type), a
Autor:
Park, Seok J., Im-Sook Song, Kang, Sun W., Hyun Joo, Kim, Tae H., Yoon, Young C., Euiyong Kim, Yeong-Lim Choi, Jae-Gook Shin, Son, Ji H., Kim, Yeong H.
Publikováno v:
Clinical Nephrology; Nov2012, Vol. 78 Issue 5, p412-417, 6p, 2 Color Photographs, 1 Black and White Photograph, 1 Chart, 2 Graphs